Healthcare provider profile · identity verified

Yasser Chebli, MD

Family Practice · SAINT PAUL, MN · NPI 1366704553

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	402	80
Eliquis	Apixaban	374	55
Furosemide	Furosemide	365	98
Gabapentin	Gabapentin	363	83
Levothyroxine Sodium	Levothyroxine Sodium	352	62
Lisinopril	Lisinopril	331	58
Amlodipine Besylate	Amlodipine Besylate	315	56
Tamsulosin Hcl	Tamsulosin Hcl	257	41
Quetiapine Fumarate	Quetiapine Fumarate	245	53
Metoprolol Tartrate	Metoprolol Tartrate	235	48
Sertraline Hcl	Sertraline Hcl	230	42
Losartan Potassium	Losartan Potassium	225	25
Rosuvastatin Calcium	Rosuvastatin Calcium	207	36
Metoprolol Succinate	Metoprolol Succinate	201	68
Pantoprazole Sodium	Pantoprazole Sodium	183	50
Trazodone Hcl	Trazodone Hcl	181	51
Omeprazole	Omeprazole	152	47
Mirtazapine	Mirtazapine	146	36
Escitalopram Oxalate	Escitalopram Oxalate	139	21
Levetiracetam	Levetiracetam	128	17
Potassium Chloride	Potassium Chloride	128	47
Citalopram Hbr	Citalopram Hydrobromide	122	22
Oseltamivir Phosphate	Oseltamivir Phosphate	118	103
Bumetanide	Bumetanide	115	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	108	22
Risperidone	Risperidone	99	suppressed
Jantoven	Warfarin Sodium	97	21
Metformin Hcl	Metformin Hcl	94	29
Hydralazine Hcl	Hydralazine Hcl	93	21
Duloxetine Hcl	Duloxetine Hcl	92	26
Carvedilol	Carvedilol	84	22
Divalproex Sodium	Divalproex Sodium	82	11
Allopurinol	Allopurinol	81	24
Lactulose	Lactulose	73	suppressed
Finasteride	Finasteride	72	16
Carbidopa-Levodopa	Carbidopa/Levodopa	70	12
Simvastatin	Simvastatin	69	23
Warfarin Sodium	Warfarin Sodium	69	16
Clopidogrel	Clopidogrel Bisulfate	65	20
Donepezil Hcl	Donepezil Hcl	65	22
Ondansetron Hcl	Ondansetron Hcl	63	22
Jardiance	Empagliflozin	60	suppressed
Spironolactone	Spironolactone	59	21
Cephalexin	Cephalexin	57	29
Xarelto	Rivaroxaban	53	13
Torsemide	Torsemide	52	20
Fluoxetine Hcl	Fluoxetine Hcl	51	14
Baclofen	Baclofen	50	11
Nyamyc	Nystatin	50	13
Ropinirole Hcl	Ropinirole Hcl	50	suppressed
Methocarbamol	Methocarbamol	48	25
Prednisone	Prednisone	48	26
Hydroxyzine Hcl	Hydroxyzine Hcl	46	14
Latanoprost	Latanoprost	46	21
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	44	16
Olanzapine	Olanzapine	43	14
Fluticasone Propionate	Fluticasone Propionate	40	22
Sulfasalazine	Sulfasalazine	40	suppressed
Famotidine	Famotidine	39	25
Oxybutynin Chloride Er	Oxybutynin Chloride	37	14
Hydrochlorothiazide	Hydrochlorothiazide	35	suppressed
Heparin Sodium	Heparin Sodium,porcine	34	suppressed
Xifaxan	Rifaximin	34	suppressed
Nystatin	Nystatin	33	22
Myrbetriq	Mirabegron	29	suppressed
Trulicity	Dulaglutide	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	15
Glimepiride	Glimepiride	27	suppressed
Memantine Hcl	Memantine Hcl	27	11
Albuterol Sulfate Hfa	Albuterol Sulfate	25	21
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	suppressed
Brilinta	Ticagrelor	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	15
Methotrexate	Methotrexate Sodium	24	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Folic Acid	Folic Acid	22	suppressed
Glipizide	Glipizide	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	11
Cefuroxime	Cefuroxime Axetil	21	19
Clozapine	Clozapine	21	suppressed
Carbamazepine	Carbamazepine	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	19	suppressed
Atenolol	Atenolol	18	suppressed
Timolol Maleate	Timolol Maleate	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Albuterol Sulfate	Albuterol Sulfate	16	13
Budesonide	Budesonide	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	suppressed
Vancomycin Hcl	Vancomycin Hcl	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Dexamethasone	Dexamethasone	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Lorazepam	Lorazepam	15	11
Metolazone	Metolazone	15	suppressed
Nystop	Nystatin	15	11
Acyclovir	Acyclovir	14	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Azithromycin	Azithromycin	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	13
Ozempic	Semaglutide	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	11	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error